Pfizer/PFE
$28.78
-0.48%-
1D1W1MYTD1YMAX
About Pfizer
Pfizer Inc. is a research-based global biopharmaceutical company. The Company is engaged in the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. Its Biopharma segment is engaged in the science-based biopharmaceutical business. Its Biopharma segment includes the Pfizer Oncology Division, the Pfizer U.S. Commercial Division, and the Pfizer International Commercial Division. Its product categories include oncology, primary care and specialty care. Its Oncology products include Ibrance, Xtandi, Inlyta, Bosulif, Lorbrena, Braftovi, Mektovi, Padcev, Adcetris, Talzenna, Tukysa, Elrexfio and Tivdak. Its primary care products include Eliquis, Nurtec ODT/Vydura, Comirnaty, the Prevnar family, Abrysvo, FSME/IMMUN-TicoVac, Paxlovid and Lucira by Pfizer. Its specialty care products include Xeljanz, Enbrel (outside the U.S. and Canada), Inflectra, Cibinqo, Litfulo, Vyndaqel family, Genotropin, Sulperazon, Zavicefta, Medrol and Panzyga.
Ticker
PFE
Sector
Healthcare
Trading on
NYSE
Industry
Biotechnology & Drugs
CEO
Albert Bourla
Employees
88,000
Headquarters
New york, United States
Website
www.pfizer.com
Pfizer Metrics
BasicAdvanced
$163B
Market cap
-
P/E ratio
-$0.06
EPS
0.68
Beta
$1.65
Dividend rate
5.83%
Dividend yield
Price and volume
Market cap
$163B
Beta
0.68023
52-week high
$40.37
52-week low
$25.20
Average daily volume
43M
Dividend rate
$1.65
Financial strength
Current ratio
1.047
Quick ratio
0.778
Long term debt to equity
66.434
Total debt to equity
75.355
Management effectiveness
Return on assets (TTM)
-0.12%
Return on equity (TTM)
-0.3%
Return on investment (TTM)
-0.15%
Valuation
Price to revenue (TTM)
2.962
Price to book
1.77
Five year average dividend yield
3.64%
Dividend yield (TTM)
5.73%
Forward dividend yield
5.83%
Growth
Revenue change (TTM)
-40.73%
Earnings per share change (TTM)
-101.2%
3-year revenue growth
11.99%
3-year earnings per share growth
-31.78%
3-year dividend per share growth
2.57%
What the Analysts think about Pfizer
Analyst Ratings
Majority rating from 26 analysts.
Price Targets
Average projection from 22 analysts.
High $45.00
Low $27.00
$28.78
Current price
$31.48
Average price target
Pfizer Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$15B
4.41%
Net income
$3.1B
-192.46%
Profit margin
20.93%
-188.54%
Pfizer Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
$0.67
-$0.17
$0.10
$0.82
-
Expected
$0.57
-$0.34
-$0.22
$0.52
$0.45
Surprise
18.02%
-49.39%
-145.84%
56.58%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.
Upcoming events
FAQs
What’s the current market cap for Pfizer stock?
Pfizer (PFE) has a market cap of $162B as of May 20, 2024.
What is the P/E ratio for Pfizer stock?
The price to earnings (P/E) ratio for Pfizer (PFE) stock is 0 as of May 20, 2024.
Does Pfizer stock pay dividends?
Yes, the Pfizer (PFE) stock pays dividends to shareholders. As of May 20, 2024, the dividend rate is $1.65 and the yield is 5.87%. Pfizer has a payout ratio of 0% on a trailing twelve-month basis.
When is the next Pfizer dividend payment date?
The next Pfizer (PFE) dividend payment is scheduled for June 14, 2024.
What is the beta indicator for Pfizer?
Pfizer (PFE) has a beta rating of 0.68. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
What is the Pfizer stock price target?
The target price for Pfizer (PFE) stock is $31.48, which is 9.92% above the current price of $28.64. This is an average based on projections from 22 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.
Buy or sell Pfizer stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.